Principal Financial Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,736
Closed -$215K 2317
2025
Q2
$215K Sell
3,736
-23,638
-86% -$1.34M ﹤0.01% 2118
2025
Q1
$1.59M Sell
27,374
-135,339
-83% -$9.24M ﹤0.01% 1797
2024
Q4
$13.1M Buy
162,713
+94,096
+137% +$8.04M 0.01% 1131
2024
Q3
$5.5M Buy
68,617
+51,030
+290% +$3.63M ﹤0.01% 1541
2024
Q2
$1.07M Sell
17,587
-3,396
-16% -$202K ﹤0.01% 1849
2024
Q1
$1.04M Buy
20,983
+10,395
+98% +$495K ﹤0.01% 1865
2023
Q4
$444K Buy
10,588
+568
+6% +$19.3K ﹤0.01% 1980
2023
Q3
$329K Sell
10,020
-247
-2% -$8.42K ﹤0.01% 2036
2023
Q2
$363K Buy
10,267
+948
+10% +$31.3K ﹤0.01% 2028
2023
Q1
$265K Sell
9,319
-24,511
-72% -$865K ﹤0.01% 2115
2022
Q4
$1.41M Buy
33,830
+25,073
+286% +$1.08M ﹤0.01% 1816
2022
Q3
$364K Sell
8,757
-14,011
-62% -$559K ﹤0.01% 2031
2022
Q2
$744K Buy
+22,768
New +$828K ﹤0.01% 1975

Other funds holding PRCT

Principal Financial Group's PRCT Position: Q3 2025 in Review

Principal Financial Group sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 3,736 shares — an estimated $215K sold.

Principal Financial Group first reported a position in PRCT in Q2 2022 and held it in 13 quarters. The position peaked at $13.1M in Q4 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Principal Financial Group reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Principal Financial Group sold 3,736 Procept Biorobotics shares in Q3 2025, an estimated $215K.
  • Principal Financial Group first reported a position in Procept Biorobotics in Q2 2022 and held it in 13 quarters.
  • Principal Financial Group's Procept Biorobotics position peaked at $13.1M in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Principal Financial Group's 13F filing for Q3 2025, filed 4 Nov 2025.